US Stock MarketDetailed Quotes

LAB Standard BioTools

Watchlist
  • 1.140
  • -0.050-4.20%
Close Mar 27 16:00 ET
  • 1.140
  • 0.0000.00%
Post 20:01 ET
432.04MMarket Cap-2.19P/E (TTM)

About Standard BioTools Company

Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.

Company Profile

SymbolLAB
Company NameStandard BioTools
Listing DateFeb 10, 2011
Founded1999
CEODr. Michael Egholm, PhD
MarketNASDAQ
Employees818
Fiscal Year Ends12-31
Address2 Tower Place,Suite 2000
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-266-6000

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Michael Egholm, PhD
  • President, Chief Executive Officer and Director
  • 1.93M
  • Jonathan Mickelsen
  • Vice President and Chief Accounting Officer
  • --
  • Sean Mackay
  • Chief Business Officer
  • --
  • Hanjoon Alex Kim
  • Chief Financial Officer and Principal Accounting Officer
  • 909.79K
  • Thomas Carey
  • Chairman of the Board
  • --
  • Kathy L. Hibbs, J.D.
  • Director
  • --
  • Troy M. Cox, M.B.A.
  • Director
  • --
  • Fenel M. Eloi
  • Independent Director
  • 311.83K
  • Eli D. Casdin, M.B.A.
  • Independent Director
  • 163.50K
  • Dr. Franklin R. Witney, PhD
  • Independent Director
  • 173.50K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More